Wolverine Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-77
Closed -$8.48K 2357
2021
Q2
$7K Buy
+77
New +$6.87K ﹤0.01% 2034
2021
Q1
Sell
-4,273
Closed -$397K 2273
2020
Q4
$408K Buy
4,273
+2,504
+142% +$258K ﹤0.01% 906
2020
Q3
$200K Sell
1,769
-1,287
-42% -$135K ﹤0.01% 985
2020
Q2
$302K Buy
+3,056
New +$244K ﹤0.01% 832

Other funds holding TNDM

Wolverine Asset Management's TNDM Position: Q3 2021 in Review

Wolverine Asset Management sold out of Tandem Diabetes Care (TNDM) in Q3 2021, closing a stake of 77 shares — an estimated $8.48K sold.

Wolverine Asset Management first reported a position in TNDM in Q2 2020 and held it in 4 quarters. The position peaked at $408K in Q4 2020. 337 funds tracked by Wall St. Rank hold TNDM as of Q3 2021.

  • Wolverine Asset Management reported no remaining Tandem Diabetes Care position as of Q3 2021 after selling out during the quarter.
  • Wolverine Asset Management sold 77 Tandem Diabetes Care shares in Q3 2021, an estimated $8.48K.
  • Wolverine Asset Management first reported a position in Tandem Diabetes Care in Q2 2020 and held it in 4 quarters.
  • Wolverine Asset Management's Tandem Diabetes Care position peaked at $408K in Q4 2020.
  • 337 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2021.

Based on Wolverine Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.